Showing results (321-330 of 384) with videos related to

Sort By:
Pageof 39
Nature Genetics|April 25, 2018
Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastomaAna C deCarvalho, Hoon Kim, Laila M Poisson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2009
Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?Kyoung Ha Kim, Jeeyun Lee, Jung-Il Lee, et al.
Clinical and Translational Radiation Oncology|June 17, 2024
Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy based-chemoradiation therapy for newly diagnosed glioblastoma: A multi-institutional studyNalee Kim, Joongyo Lee, Hyunju Shin, et al.
Nature Communications|August 6, 2020
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomasBarbara Oldrini, Nuria Vaquero-Siguero, Quanhua Mu, et al.
The Journal of Clinical Investigation|July 25, 2017
Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2Jia Wang, Peng Cheng, Marat S Pavlyukov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 19, 2008
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomasKyeung Min Joo, Shi Yean Kim, Xun Jin, et al.
Plos One|August 2, 2014
Translational validation of personalized treatment strategy based on genetic characteristics of glioblastomaYoung Taek Oh, Hee Jin Cho, Jinkuk Kim, et al.
Cancer Discovery|November 17, 2012
Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cellsYu Ding, Christopher G Hubert, Jacob Herman, et al.
Neuro-Oncology|June 26, 2018
Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastomaJason K Sa, Sung Heon Kim, Jin-Ku Lee, et al.
JCI Insight|October 3, 2023
The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signalingHye-Min Jeon, Yong Jae Shin, Jaehyun Lee, et al.
Pageof 39